This year's Cellular Therapeutics in Trauma and Critical Care (CTTACC) conference is being held in San Diego from December 11-13. The two-and-a-half day conference is presented by the University of California San Francisco Department of Laboratory Medicine. The goal of this meeting is to bring together the expertise and input of a multidisciplinary group of blood banks, clinicians, basic scientists, industry, academia, FDA, NIH, AABB, BARDA and DOD representatives to discuss the state of the science and existing barriers in the translation of these novel therapies in trauma and critical care. Regulatory insight will be included from the FDA.
Hope Biosciences is a proud sponsor of the event. Visit cttacc.org to learn more!
